Dracorhodin Perochlorate Attenuates Staphylococcus Aureus USA300 Virulence by Decreasing α-toxin Expression

Overview

Journal World J Microbiol Biotechnol

Publisher Springer

Specialties Biotechnology
Microbiology

Date 2016 Dec 1

PMID 27900629

Citations 6

Authors

Yumin Liu

Dongxue Shi

Yan Guo

Meng Li

Yonghong Zha

Quankai Wang

Jianfeng Wang

Affiliations

Soon will be listed here.

Abstract

α-Toxin, a pore-forming toxin secreted by most Staphylococcus aureus, plays critical role in the pathogenesis associated with various infectious diseases. The USA300 which is a major international epidemic methicilin-resisrant S. aureus has spread rapidly to multiple countries and become an emerging public health concern. In this study, the in vitro efficacy of Dracorhodin Perochlorate (DP) against USA300 virulence was evaluated. Using susceptibility testing, immunoblots, rabbit blood haemolytic assay and real-time RT-PCR, we observed that the α-toxin production was decreased when USA300 was co-cultured with different sub-inhibitory concentration of DP. Further, the protective effect of DP against USA300-mediated injury of human alveolar epithelial cells (A549) and MH-S cells was evaluated by cytotoxicity assays, and the result revealed that DP, at final concentration of 16 µg/ml, is a potent antagonist for USA300-mediated cell damage. Importantly, those beneficial effects might partially correlate with hla and RNAIII suppression by DP, leading to the inhibition of α-toxin production in culture supernatant. Overall, these results suggest that DP could attenuate the virulence of USA300 by decreasing α-toxin production without inhibiting bacterial growth, and this compound may represent an ideal candidate for the development of anti-virulence agent combating S. aureus infection.

Citing Articles

Anti-virulence therapeutic strategies against bacterial infections: recent advances.

Dehbanipour R, Ghalavand Z Germs. 2022; 12(2):262-275.

PMID: 36504617 PMC: 9719373. DOI: 10.18683/germs.2022.1328.

2,3-Dehydrokievitone combats methicillin-resistant infection by reducing alpha-hemolysin expression.

Yu H, Liu J, Wang L, Guan S, Jin Y, Zheng J Front Microbiol. 2022; 13:969215.

PMID: 36090058 PMC: 9454091. DOI: 10.3389/fmicb.2022.969215.

Plant Derived Natural Products against and : Antibiofilm Activity and Molecular Mechanisms.

Guzzo F, Scognamiglio M, Fiorentino A, Buommino E, DAbrosca B Molecules. 2020; 25(21).

PMID: 33138250 PMC: 7663672. DOI: 10.3390/molecules25215024.

Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activity.

Liu Y, Wang Z, Ma C, Wei Z, Chen K, Wang C J Cell Mol Med. 2020; 24(6):3303-3313.

PMID: 31965715 PMC: 7131942. DOI: 10.1111/jcmm.15003.

Identification of hemolytic activity and hemolytic genes of Methicillin-resistant Staphylococcus aureus isolated from Chinese children.

Wang L, Yang X, Qian S, Liu Y, Yao K, Dong F Chin Med J (Engl). 2020; 133(1):88-90.

PMID: 31923109 PMC: 7028192. DOI: 10.1097/CM9.0000000000000571.

References

Daly S, Elmore B, Kavanaugh J, Triplett K, Figueroa M, Raja H . ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Antimicrob Agents Chemother. 2015; 59(4):2223-35. PMC: 4356798. DOI: 10.1128/AAC.04564-14. View

Foster T, Geoghegan J, Ganesh V, Hook M . Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2013; 12(1):49-62. PMC: 5708296. DOI: 10.1038/nrmicro3161. View

Skov R, Christiansen K, Dancer S, Daum R, Dryden M, Huang Y . Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents. 2012; 39(3):193-200. DOI: 10.1016/j.ijantimicag.2011.09.029. View

Yu J, Zheng G, Liu C, Zhang L, Gao H, Zhang Y . Dracorhodin perchlorate induced human breast cancer MCF-7 apoptosis through mitochondrial pathways. Int J Med Sci. 2013; 10(9):1149-56. PMC: 3714391. DOI: 10.7150/ijms.6275. View

Stefani S, Chung D, Lindsay J, Friedrich A, Kearns A, Westh H . Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents. 2012; 39(4):273-82. DOI: 10.1016/j.ijantimicag.2011.09.030. View

Strommenger B, Bartels M, Kurt K, Layer F, Rohde S, Boye K . Evolution of methicillin-resistant Staphylococcus aureus towards increasing resistance. J Antimicrob Chemother. 2013; 69(3):616-22. DOI: 10.1093/jac/dkt413. View

Gould I, David M, Esposito S, Garau J, Lina G, Mazzei T . New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents. 2011; 39(2):96-104. DOI: 10.1016/j.ijantimicag.2011.09.028. View

Watkins R, David M, Salata R . Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2012; 61(Pt 9):1179-1193. PMC: 4080747. DOI: 10.1099/jmm.0.043513-0. View

Kobayashi S, Malachowa N, Whitney A, Braughton K, Gardner D, Long D . Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis. 2011; 204(6):937-41. PMC: 3156927. DOI: 10.1093/infdis/jir441. View

10.

van Hal S, Fowler Jr V . Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?. Clin Infect Dis. 2013; 56(12):1779-88. PMC: 3658366. DOI: 10.1093/cid/cit178. View

11.

Mediavilla J, Chen L, Mathema B, Kreiswirth B . Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 2012; 15(5):588-95. DOI: 10.1016/j.mib.2012.08.003. View

12.

Berube B, Bubeck Wardenburg J . Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel). 2013; 5(6):1140-66. PMC: 3717774. DOI: 10.3390/toxins5061140. View

13.

Zhou X, Liu S, Li W, Zhang B, Liu B, Liu Y . Phloretin derived from apple can reduce alpha-hemolysin expression in methicillin-resistant Staphylococcus aureus USA300. World J Microbiol Biotechnol. 2015; 31(8):1259-65. DOI: 10.1007/s11274-015-1879-1. View

14.

Chen Y, Yeh A, Cheung G, Villaruz A, Tan V, Joo H . Basis of virulence in a Panton-Valentine leukocidin-negative community-associated methicillin-resistant Staphylococcus aureus strain. J Infect Dis. 2014; 211(3):472-80. PMC: 4296174. DOI: 10.1093/infdis/jiu462. View

15.

Tavares A, Nielsen J, Boye K, Rohde S, Paulo A, Westh H . Insights into alpha-hemolysin (Hla) evolution and expression among Staphylococcus aureus clones with hospital and community origin. PLoS One. 2014; 9(7):e98634. PMC: 4102472. DOI: 10.1371/journal.pone.0098634. View

16.

Sully E, Malachowa N, Elmore B, Alexander S, Femling J, Gray B . Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog. 2014; 10(6):e1004174. PMC: 4055767. DOI: 10.1371/journal.ppat.1004174. View

17.

Xia M, Wang D, Wang M, Tashiro S, Onodera S, Minami M . Dracorhodin perchlorate induces apoptosis via activation of caspases and generation of reactive oxygen species. J Pharmacol Sci. 2004; 95(2):273-83. DOI: 10.1254/jphs.fpj03102x. View

18.

DeLeo F, Otto M, Kreiswirth B, Chambers H . Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010; 375(9725):1557-68. PMC: 3511788. DOI: 10.1016/S0140-6736(09)61999-1. View

19.

Seybold U, Kourbatova E, Johnson J, Halvosa S, Wang Y, King M . Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006; 42(5):647-56. DOI: 10.1086/499815. View

20.

Enright M, Robinson D, Randle G, Feil E, Grundmann H, Spratt B . The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002; 99(11):7687-92. PMC: 124322. DOI: 10.1073/pnas.122108599. View